Vanguard Group Inc Verrica Pharmaceuticals Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,168,310 shares of VRCA stock, worth $17.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,168,310
Previous 2,361,321
8.17%
Holding current value
$17.2 Million
Previous $18.8 Million
8.17%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding VRCA
# of Institutions
55Shares Held
16.5MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY8.88MShares$70.6 Million1.24% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny907KShares$7.21 Million0.0% of portfolio
-
Sovran Advisors, LLC San Diego, CA750KShares$5.97 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA646KShares$5.14 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...